Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026

BOSTON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, November 3, 2026 to report its third quarter 2026 financial results and provide a corporate update.

Also today, Rhythm announced participation in two upcoming investor conferences: * David Meeker, M.D., Chairman, President and Chief Executive Officer will participate in a fireside chat at the Guggenheim 3(rd) Annual Healthcare Innovation Conference on Monday, November 9 at 9:00 a.m. ET. * Hunter Smith, Chief Financial Officer, will participate in a fireside chat at the Stifel 2026 Healthcare Conference on Wednesday, November 11 at 11:20 a.m. ET. Live webcasts of both the financial results conference call and the fireside chats will be available under "Events and Presentations" in the Investor Relations section of the Rhythm Pharmaceuticals website at http://ir.rhythmtx.com/. The archived webcast of the financial results conference call will be available on Rhythm’s website approximately two hours after it concludes and will be available for 30 days following the call. A replay of the fireside chats will also be available on the Rhythm website for 30 days following the presentation.